Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palifermin for T-cell Reconstitution in Haploidentical Transplant
NCT00570999Phase 2Withdrawn
- Start
- Feb 2008
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of palifermin in non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), myelodysplastic syndrome (MDS). Planned start Feb 2008; status: withdrawn.
02
Drugs
palifermin
03
Conditions
non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)acute myeloid leukemia (AML)acute lymphocytic leukemia (ALL)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00570999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00570999.